DNA immunotherapy for recurrent respiratory papillomatosis (RRP): phase 1/2 study assessing efficacy, safety, and immunogenicity of INO-3107 by Matthew P. Morrow, Elisabeth Gillespie, Albert Sylvester, Milan R. Amin, Peter C. Belafsky, Simon R. Best, Aaron D. Friedman, Adam M. Klein, David G. Lott, Ted Mau, Randal C. Paniello, Seth M. Pransky, Nabil F. Saba, Grace S. Tan, Sadie Wisotsky, Sarah A. Marcus, Emma L. Reuschel, Katherine S. Reed, David B. Weiner, Michael Dallas, Jeffrey M. Skolnik

Get full text